Further, since other IER5 family genes (IER2 and IER5L) have also been reported to regulate HSF1 activity, this family of genes may collectively be involved in the progression of ovarian cancer via the HSF1 pathway. This evidence concerns the gene IER2 and ovarian carcinoma.